IGM Biosciences, Inc. Deferred Offering Costs
IGM Biosciences, Inc. had Deferred Offering Costs of $0 as of 2020-12-31, per its 10-K filed 2021-03-30.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2021-03-30
- 2020-12-31: Deferred Offering Costs $0.00.
- 2019-12-31: Deferred Offering Costs $0.00.
| Period end | Deferred Offering Costs |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-30 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-30 |